Cardinal Health, Inc. $CAH Shares Sold by Ironwood Investment Counsel LLC

Ironwood Investment Counsel LLC decreased its holdings in Cardinal Health, Inc. (NYSE:CAHFree Report) by 11.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 22,395 shares of the company’s stock after selling 2,823 shares during the period. Ironwood Investment Counsel LLC’s holdings in Cardinal Health were worth $4,602,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of CAH. Aventura Private Wealth LLC acquired a new position in shares of Cardinal Health during the fourth quarter worth $25,000. Elyxium Wealth LLC acquired a new position in shares of Cardinal Health during the fourth quarter worth $34,000. Barnes Dennig Private Wealth Management LLC grew its stake in shares of Cardinal Health by 38.7% during the fourth quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock worth $39,000 after purchasing an additional 53 shares in the last quarter. JPL Wealth Management LLC acquired a new position in shares of Cardinal Health during the third quarter worth $31,000. Finally, Turning Point Benefit Group Inc. acquired a new position in shares of Cardinal Health during the third quarter worth $31,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Wall Street Analysts Forecast Growth

CAH has been the subject of a number of analyst reports. UBS Group set a $260.00 target price on shares of Cardinal Health and gave the stock a “buy” rating in a research note on Friday, February 6th. Morgan Stanley boosted their target price on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 28th. Argus boosted their target price on shares of Cardinal Health from $232.00 to $248.00 and gave the stock a “buy” rating in a research note on Wednesday, February 11th. Evercore lowered their target price on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. Finally, Citigroup lowered their target price on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $241.80.

View Our Latest Report on Cardinal Health

Cardinal Health Price Performance

Shares of CAH opened at $195.10 on Monday. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60. The stock has a market cap of $45.69 billion, a PE ratio of 29.83, a price-to-earnings-growth ratio of 1.16 and a beta of 0.53. The firm has a fifty day moving average price of $206.96 and a 200 day moving average price of $208.10.

Cardinal Health (NYSE:CAHGet Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. During the same period in the previous year, the company earned $2.35 earnings per share. Cardinal Health’s quarterly revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts expect that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a yield of 1.1%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s dividend payout ratio is presently 31.19%.

Cardinal Health Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Recommended Stories

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.